<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/83D87776-5958-42AE-889D-B8AECF16B468"><gtr:id>83D87776-5958-42AE-889D-B8AECF16B468</gtr:id><gtr:name>University of Leeds</gtr:name><gtr:address><gtr:line1>University of Leeds</gtr:line1><gtr:line4>Leeds</gtr:line4><gtr:line5>West Yorkshire</gtr:line5><gtr:postCode>LS2 9JT</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/B936D768-A528-4ABB-A6FA-D5F91D6FD0F4"><gtr:id>B936D768-A528-4ABB-A6FA-D5F91D6FD0F4</gtr:id><gtr:name>Defence Science &amp; Technology Laboratory (DSTL)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C842A34F-18F7-454D-A259-FED802368496"><gtr:id>C842A34F-18F7-454D-A259-FED802368496</gtr:id><gtr:name>University of Leicester</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Leicester</gtr:line4><gtr:line5>Leicestershire</gtr:line5><gtr:postCode>LE1 7RH</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/C842A34F-18F7-454D-A259-FED802368496"><gtr:id>C842A34F-18F7-454D-A259-FED802368496</gtr:id><gtr:name>University of Leicester</gtr:name><gtr:department>Chemistry</gtr:department><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Leicester</gtr:line4><gtr:line5>Leicestershire</gtr:line5><gtr:postCode>LE1 7RH</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C842A34F-18F7-454D-A259-FED802368496"><gtr:id>C842A34F-18F7-454D-A259-FED802368496</gtr:id><gtr:name>University of Leicester</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Leicester</gtr:line4><gtr:line5>Leicestershire</gtr:line5><gtr:postCode>LE1 7RH</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/83D87776-5958-42AE-889D-B8AECF16B468"><gtr:id>83D87776-5958-42AE-889D-B8AECF16B468</gtr:id><gtr:name>University of Leeds</gtr:name><gtr:address><gtr:line1>University of Leeds</gtr:line1><gtr:line4>Leeds</gtr:line4><gtr:line5>West Yorkshire</gtr:line5><gtr:postCode>LS2 9JT</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/B936D768-A528-4ABB-A6FA-D5F91D6FD0F4"><gtr:id>B936D768-A528-4ABB-A6FA-D5F91D6FD0F4</gtr:id><gtr:name>Defence Science &amp; Technology Laboratory (DSTL)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/1AA544DD-AD04-492F-8B1E-2CBF7705D749"><gtr:id>1AA544DD-AD04-492F-8B1E-2CBF7705D749</gtr:id><gtr:firstName>Andrew</gtr:firstName><gtr:surname>Jamieson</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=EP%2FL018152%2F1"><gtr:id>01D1323A-A521-44A2-8812-0BB70FC0344D</gtr:id><gtr:title>1,3-Diyne Constrained alpha-Helix Peptides: New tools for Interrogating Protein-Protein Interactions</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>EP/L018152/1</gtr:grantReference><gtr:abstractText>In this research project, we will develop an innovative new experimental method to conformationally constrain peptides to fold into an alpha-helix secondary structure. The resulting molecules will be useful chemical tools for the regulation of protein-protein interactions.
Protein-protein interactions are involved in the regulation of cellular functions and represent attractive targets to medicinal chemists. While these molecular recognition events involve interactions over large surface areas, the majority of the binding affinity and specificity has been found to originate from constellations of a few amino acid residues that are described as interaction 'hotspots'. At a molecular level, these constellations of residues are frequently found to be specific protein secondary structures such as the alpha-helix, beta-strand/sheet and turn conformations. These structural motifs present molecular functionality with the correct orientation and spacing to interact with complementing functionality on the partner protein. Although the helical motif is usually thermodynamically favoured in folded proteins, isolated peptides typically lack the ability to spontaneously adopt the helical conformation. Efforts to excise specific helical motifs from an active protein sequence have thus necessitated synthetic modifications to link distant residues to induce an alpha-helix conformation. These conformational constraints have been used to produce alpha-helical peptide mimics for probing protein-protein interaction binding surfaces and have in some instances furnished lead compounds for drug discovery. However, in many examples the functionality linking the distant amino acid residues is too flexible to induce helical structure and so does not act as a conformational constraint or improve the physicochemical properties of the peptide. In this project we will address this challenge by developing a highly rigid conformational constraint based on a 1,3-diyne side-chain to side-chain bridge and produce functional tool compounds to investigate protein-protein interactions.</gtr:abstractText><gtr:potentialImpactText>This research project has the potential to have significant and wide-ranging impact. Our aim is to develop the chemistry required to produce new peptide tools that will be used to regulate protein-protein interactions. 
The new chemical biology tools we propose could impact a diverse range of beneficiaries including academics, the pharmaceutical industry and the general public. We plan to engage with beneficiaries in academia and the pharmaceutical industry through dissemination of our research results in high impact journals, at conferences (both home and abroad) and through professional networks (e.g. Protein-Protein Interaction Network). The general public will also be engaged with our research using news articles appearing on our website and through social networking sites.
Conformationally constrained peptides are a potential new class of therapeutic agent that possess the high affinity and specificity of biologics (i.e. protein therapeutics) and also the pharmacokinetic properties of small molecules. Our second objective in this project is to produce conformationally constrained peptide mimics of the SMRT corepressor and assess its ability to regulate the HDAC3/corepressor protein-protein interaction. At this stage we will seek to protect the intellectual property associated with potential lead compounds and use this as leverage to obtain funding to establish a spinout company. This company will have a positive impact on the UK economy by providing employment and training for skilled workers. If successful, the company would also have a positive impact on peoples health and well being by providing improved therapeutics. 
The postdoctoral researcher will present the proposed research at the Houses of Parliament as part of the SET for Britain competition. We will use this as a platform to engage with politicians in order to influence UK scientific policy.</gtr:potentialImpactText><gtr:fund><gtr:end>2015-07-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/798CB33D-C79E-4578-83F2-72606407192C"><gtr:id>798CB33D-C79E-4578-83F2-72606407192C</gtr:id><gtr:name>EPSRC</gtr:name></gtr:funder><gtr:start>2014-02-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>98498</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Leicester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Martin Dyer and Meike Vogler - BIM/Bcl2</gtr:description><gtr:id>F507C57C-83EA-4E0E-93EA-1C9B2569089C</gtr:id><gtr:impact>Jamieson group - synthetic chemistry
Dyer Group - cancer 
Vogler Group - cancer cell biology</gtr:impact><gtr:outcomeId>56dd7e904c5005.63083007-1</gtr:outcomeId><gtr:partnerContribution>Biological evaluation of conformationally constrained BIM peptides in B-cells.</gtr:partnerContribution><gtr:piContribution>Synthesis of conformationally constrained BIM peptides.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Leicester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>HDAC project</gtr:description><gtr:id>B3399555-9CFC-4728-907F-77AEE17A9D06</gtr:id><gtr:impact>G. M. Hudson, P. Watson, L. Fairall, A. G. Jamieson, J. W. R. Schwabe, Insights into the recruitment of class IIa HDACs to the SMRT/NCoR transcriptional repression complex. J. Bio. Chem., 2015, 290, 18237-18244.

P. J. Watson, C. J. Millard, A. M. Riley, N. S. Robertson, L. C. Wright, H. Y. Godage, S. M. Cowley, A. G. Jamieson, B. V. L. Potter, John W. R. Schwabe, The mechanism of activation of class I HDAC complexes by inositol phosphates. Nat. Commun., accepted</gtr:impact><gtr:outcomeId>5463b0c553c249.30663063-1</gtr:outcomeId><gtr:partnerContribution>HDAC activity assay for biological evaluation of peptidomimetics</gtr:partnerContribution><gtr:piContribution>Peptidomimetic regulators of HDAC activity</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Defence Science &amp; Technology Laboratory (DSTL)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>DSTL - VGSC/conotoxins</gtr:description><gtr:id>4CD0AC86-7CAC-4CF3-9C32-AC22796D8972</gtr:id><gtr:impact>No outputs as yet.</gtr:impact><gtr:outcomeId>56dd7f557c05e9.73646447-1</gtr:outcomeId><gtr:partnerContribution>Biological evaluation of conotoxin mimetics</gtr:partnerContribution><gtr:piContribution>Synthesis of conotoxin mimetics</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Leeds</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Biochemistry and Microbiology Leeds</gtr:department><gtr:description>Proteomimetic Probes to Determine the Structural requirements of TPX2 for Activation of Protein Kinase Aurora-A</gtr:description><gtr:id>75DC416F-D411-4D3A-AC08-8266B02FB789</gtr:id><gtr:impact>Yana Rennie, Patrick J. McIntyre, Richard Bayliss, Andrew G Jamieson, Proteomimetic Probes to Determine the Structural requirements of TPX2 for Activation of Protein Kinase Aurora-A. Manuscript in preparation.</gtr:impact><gtr:outcomeId>56dd68c70b02b1.96237548-1</gtr:outcomeId><gtr:partnerContribution>Evaluation of TPX2 proteomimetic binding to Aurora-A using ITC and activity based assays.</gtr:partnerContribution><gtr:piContribution>Solid phase synthesis of TPX2 proteomimetics</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Invited Research Seminars</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>50B4ABDB-0A85-4B0E-97DA-D64384670A0E</gtr:id><gtr:impact>Invited research seminars at Universities of Dundee, Durham, Nottingham Trent, Lincoln &amp;amp; Strathclyde. Invoked discussion and debate regarding the use of stapled peptides in chemical biology and drug discovery.</gtr:impact><gtr:outcomeId>56dd6f60097901.71489796</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2013,2014,2015,2016</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>129566</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Leverhulme Trust Project Grant</gtr:description><gtr:end>2017-03-02</gtr:end><gtr:fundingOrg>The Leverhulme Trust</gtr:fundingOrg><gtr:fundingRef>RPG-2014-372</gtr:fundingRef><gtr:id>B13DC637-21B8-429F-8E2E-A9C01506D35F</gtr:id><gtr:outcomeId>56dd652c8c1067.60667166</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>240000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Defence Science and Technology Laboratory (DSTL) project grant</gtr:description><gtr:end>2018-03-02</gtr:end><gtr:fundingOrg>Defence Science &amp; Technology Laboratory (DSTL)</gtr:fundingOrg><gtr:fundingRef>DSTLX1000100329</gtr:fundingRef><gtr:id>8FF2C29E-58B0-4B31-8275-A958FAB2E975</gtr:id><gtr:outcomeId>56dd65e8272cc4.44585114</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2016-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>195000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>University Central Infrastructure Fund</gtr:description><gtr:end>2016-07-02</gtr:end><gtr:fundingOrg>University of Leicester</gtr:fundingOrg><gtr:id>FB9D03D4-4E3F-47C5-8E34-EC99B5C4873E</gtr:id><gtr:outcomeId>56dd6690832cf2.40845649</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>20000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Confidence in Concept award</gtr:description><gtr:end>2016-12-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>12D4E47C-E7F2-499F-A104-9C06F11AA17A</gtr:id><gtr:outcomeId>56dd66479ab727.80283000</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-12-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>We have developed a novel method with which to prepare non-native amino acids. These amino acids are proving to be extremely useful as building blocks to produce biotheraputic drug molecules called &amp;quot;girder peptides&amp;quot; and also for producing synthetic proteins with unatural functions. We have now used these girder peptides to target Bcl-2 in cancer.</gtr:description><gtr:exploitationPathways>Our hope is that this technology will be used by other research groups to target protein-protein interactions mediated by an alpha-helix at the binding interface. 
Within our own group we are applying the technology to produce girder peptides that target a number of different biochemical pathways involved in cancer (c-Myc/Max, BIM/Bcl2, HDAC/corepressor and Aurora-A/TPX2) and severe pain (VGSC/conotoxins).</gtr:exploitationPathways><gtr:id>54A38EC4-5F9F-4F01-BE0C-3278674837FE</gtr:id><gtr:outcomeId>56dd784d9e34c4.28264737</gtr:outcomeId><gtr:sectors><gtr:sector>Aerospace, Defence and Marine,Agriculture, Food and Drink,Chemicals,Education,Healthcare,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Efficient asymmetric synthesis of unnatural alkenyl amino acids required for peptide 'stapling' has been achieved using alkylation of a fluorine-modified NiII Schiff base complex as the key step</gtr:description><gtr:id>7C137C57-628C-4719-8429-B173339CEF7D</gtr:id><gtr:impact>N/A</gtr:impact><gtr:outcomeId>5463b17e4a48a1.32323119</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Asymmetric Synthesis of alpha,alpha-disubstituted amino acids</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>B4CE691C-CDD3-4126-98A3-B11288CB0987</gtr:id><gtr:title>Regulation of protein?protein interactions using stapled peptides</gtr:title><gtr:parentPublicationTitle>Reports in Organic Chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5308dccba8f2f6b6b90d1cbea2308d70"><gtr:id>5308dccba8f2f6b6b90d1cbea2308d70</gtr:id><gtr:otherNames>Jamieson A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>56dd5d7387dcc7.30322436</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FA1DAA8B-AA76-4BA0-B4D4-A15E0A6389CB</gtr:id><gtr:title>Insights into the Recruitment of Class IIa Histone Deacetylases (HDACs) to the SMRT/NCoR Transcriptional Repression Complex.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3a32c648b48b6c300aeddffda22c7a7d"><gtr:id>3a32c648b48b6c300aeddffda22c7a7d</gtr:id><gtr:otherNames>Hudson GM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>56dd5d73a61923.13363054</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F9B50070-A381-4B76-9594-181D68603DFF</gtr:id><gtr:title>Robust asymmetric synthesis of unnatural alkenyl amino acids for conformationally constrained a-helix peptides.</gtr:title><gtr:parentPublicationTitle>Organic &amp; biomolecular chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1d3f8ab2f49c7e1b51cf64dfee87c8e8"><gtr:id>1d3f8ab2f49c7e1b51cf64dfee87c8e8</gtr:id><gtr:otherNames>Aillard B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1477-0520</gtr:issn><gtr:outcomeId>5463a6a4cf72d5.41232394</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2A874726-D5F5-49B0-A3F2-1088D391177E</gtr:id><gtr:title>A TPX2 Proteomimetic Has Enhanced Affinity for Aurora-A Due to Hydrocarbon Stapling of a Helix.</gtr:title><gtr:parentPublicationTitle>ACS chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e55e6695a5c527fd1e88675d72ffb0e9"><gtr:id>e55e6695a5c527fd1e88675d72ffb0e9</gtr:id><gtr:otherNames>Rennie YK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1554-8929</gtr:issn><gtr:outcomeId>585d7745e264c3.19846026</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">EP/L018152/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects><gtr:researchSubject><gtr:id>F442B6BE-8B89-4C01-8D3B-E8A4D320B672</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Biomolecules &amp; biochemistry</gtr:text></gtr:researchSubject></gtr:researchSubjects><gtr:researchTopics><gtr:researchTopic><gtr:id>02567418-12CB-462E-9092-530C6E63B359</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Chemical Biology</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>